Claudio Giuliano - Helsinn | 人才画像

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 28 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Growth Hormone Secretagogue Receptor 1a Agonists, Anamorelin and Ipamorelin, Inhibit Cisplatin-Induced Weight Loss in Ferrets: Anamorelin Also Exhibits Anti-Emetic Effects Via a Central Mechanism

Zengbing Lu,Man P. Ngan,Julia Y. H. Liu,Lingqing Yang,Longlong Tu,Sze Wa Chan,Claudio Giuliano,Emanuela Lovati,Claudio Pietra,John A. Rudd

PHYSIOLOGY & BEHAVIOR (2024)

引用0浏览0WOS引用

Preclinical Evaluation of the Blood-Brain Barrier Permeability and Intracranial Efficacy of the Next-Generation RET Inhibitor Vepafestinib

Igor Odintsov,Kentaro Wakayama,Tom Zhang, Satoru Iguchi,Masanori Kato,Allan J. W. Lui,Inna Khodos,Morana Vojnic,Claudio Giuliano,Annalisa Bonifacio,Monika A. Davare,Elisa de Stanchina,Emanuela Lovati, Marc Ladanyi,Isao Miyazaki,Romel Somwar

MOLECULAR CANCER THERAPEUTICSno. 12 (2023)

引用0浏览0引用

Efficacy of vepafestinib in preclinical models of RET fusion-driven sarcoma models

Igor Odintsov, Ryan C. Cheng,Allan J. Lui,Tom Zhang,Yue C. Lu,Renate I. Kurth,Morana Vojnic,Inna Khodos,Qing Chang,Kevin Chen,Claudio Giuliano,Annalisa Bonifacio,Isao Miyazaki,Elisa de Stanchina,Emanuela Lovati,Marc Ladanyi,Romel Somwar

CANCER RESEARCHno. 7 (2023)

引用0浏览0引用

Abstract 4007: Efficacy of Vepafestinib in Preclinical Models of RET Fusion-Driven Sarcoma Models

Igor Odintsov, Ryan C. Cheng,Allan J. Lui,Tom Zhang, Yue C. Lu,Renate I. Kurth,Morana Vojnic,Inna Khodos,Qing Chang, Kevin Chen,Claudio Giuliano,Annalisa Bonifacio,Isao Miyazaki,Elisa de Stanchina,Emanuela Lovati,Marc Ladanyi,Romel Somwar

Cancer Researchno. 7_Supplement (2023): 4007-4007

引用0浏览0引用

Chlormethine Gel for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma: in Vitro Release and Permeation Testing

Claudio Giuliano, Stefano Frizzarin, Alessandro Alonzi, Virginia Stimamiglio,Pablo L. Ortiz-Romero

Dermatology and Therapy（2022）

引用3浏览0WOS引用

Comparison of TAS0953/HM06 and selpercatinib in RET fusion-driven preclinical disease models of intracranial metastases

Igor Odintsov,Allan J.W. Lui,Kota Ishizawa,Isao Miyazaki,Inna Khodos,Kentaro Wakayama,Morana Vojnic,Connor J. Hagen,Qing Chang,Annalisa Bonifacio,Claudio Giuliano,Elisa de Stanchina,Emanuela Lovati,Emily Cheng,Marc Ladanyi,Romel Somwar

Journal of Clinical Oncology（2022）

引用7浏览0引用

Challenges in the Development of Intravenous Neurokinin-1 Receptor Antagonists: Results of a Safety and Pharmacokinetics Dose-Finding, Phase 1 Study of Intravenous Fosnetupitant

Timothy Tyler,Armin Schultz,Alessio Venturini,Claudio Giuliano,Alberto Bernareggi,Riccardo Spezia,Daniel Voisin,Valentino Stella

Clinical pharmacology in drug development（2022）

引用1浏览0WOS引用

TAS0953/HM06 is effective in preclinical models of diverse tumor types driven by RET alterations

Igor Odintsov,Renate I. Kurth,Kota Ishizawa,Lukas Delasos,Allan J. W. Lui,Inna Khodos,Connor J. Hagen,Qing Chang,Marissa S. Mattar,Morana Vojnic,Siddharth Kunte,Annalisa Bonifacio,Claudio Giuliano,Elisa De Stanchina,Emily Cheng,Emanuela Lovati,Marc Ladanyi,Romel Somwar

Poster Presentations - Proffered Abstractsno. 12 (2021)

引用2浏览0引用

The Brain-Penetrating, Orally Bioavailable, Ghrelin Receptor Agonist HM01 Ameliorates Motion-Induced Emesis in Suncus Murinus (house Musk Shrew)

Longlong Tu,Zengbing Lu,Man P. Ngan,Francis F. Y. Lam,Claudio Giuliano,Emanuela Lovati,Claudio Pietra,John A. Rudd

British journal of pharmacologyno. 7 (2020): 1635-1650

引用6浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn